FLXN Flexion Therapeutics, Inc.

21.74
+1.15  (6%)
Previous Close 20.59
Open 20.88
Price To book 3.94
Market Cap 690.40M
Shares 31,757,000
Volume 991,592
Short Ratio 6.97
Av. Daily Volume 807,658

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

PDUFA date October 6, 2017.
Zilretta - FX006
Osteoarthritis of the knee
Phase 2 top-line data released November 2016.
Zilretta - FX006
Osteoarthritis of the knee with type 2 adult diabetes

Latest News

  1. Flexion Therapeutics Named One of Boston Business Journal’s Best Places to Work
  2. Flexion Therapeutics to Present Data on Zilretta™ (FX006) at the American Diabetes Association’s 77th Scientific Sessions
  3. Flexion CEO on developing an alternative to opioids
  4. Flexion to Present New Cost-Effectiveness Data on Zilretta™ (FX006) at the International Society for Pharmacoeconomics and Outcomes Research 22nd International Meeting
  5. Flexion Therapeutics Announces Upcoming Data Presentation at the American Diabetes Association's 77th Scientific Sessions
  6. Another top executive at ​Sanofi Genzyme leaves company
  7. Edited Transcript of FLXN earnings conference call or presentation 4-May-17 8:30pm GMT
  8. Flexion Therapeutics reports 1Q loss
  9. Flexion Therapeutics Reports First Quarter 2017 Financial Results and Recent Business Highlights
  10. Investor Network: Flexion Therapeutics, Inc. to Host Earnings Call
  11. Flexion Therapeutics to Present at the Deutsche Bank 42nd Annual Health Care Conference
  12. Flexion Therapeutics Highlights Two Clinical Data Presentations at the Osteoarthritis Research Society International 2017 World Congress
  13. Flexion Therapeutics Announces Pricing of $175 Million 3.375% Convertible Senior Notes due 2024
  14. Why Flexion Therapeutics Inc. Stock Is Tanking
  15. Biotech Movers: Akebia Soars on Expanded Partnership With Otsuka
  16. Flexion Therapeutics Announces Proposed Convertible Senior Notes Offering
  17. Flexion Therapeutics to Report First-Quarter 2017 Financial Results on May 4, 2017
  18. Why Flexion Therapeutics' New Pain Drug Could Be a Game-Changer
  19. Can Drugmakers Cure the Opioid Crisis?
  20. Shark Bites: You Don't Want to Play the Gambler Today